b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29792535</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>11</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>11</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1557-7740</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>21</Volume>\n                    <Issue>9</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>09</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of palliative medicine</Title>\n                <ISOAbbreviation>J Palliat Med</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1334-1338</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1089/jpm.2018.0023</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">More than 80% of patients with advanced cancer develop weight loss. Because preclinical data suggest poly (ADP-ribose) polymerase (PARP) inhibitors can treat this weight loss, this study was undertaken to explore the PARP inhibitor veliparib for this indication.</AbstractText>\n                <AbstractText Label="OBJECTIVE">The current study was undertaken to analyze prospectively gathered data on weight in cancer patients on PARP inhibitors.</AbstractText>\n                <AbstractText Label="DESIGN/SETTING">The current study relied on a previously published, prospectively conducted phase 1 single institution trial that combined veliparib and topotecan (NCT01012817) as antineoplastic therapy for advanced cancer patients. Serial weight data and, when available and clinically relevant, computerized tomography scans were also examined.</AbstractText>\n                <AbstractText Label="MEASUREMENTS">The primary endpoint was 10% or greater weight gain from trial enrollment.</AbstractText>\n                <AbstractText Label="RESULTS">Nearly all 60 patients lost weight over time. Only one patient manifested a 10% or greater gain in weight. However, review of computerized tomography L3 images showed this weight gain was a manifestation of ascites. Four other patients gained 5% of their baseline weight. However, findings in two patients with available radiographs showed no evidence of muscle augmentation.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">The addition of the PARP inhibitor veliparib to chemotherapy does not appear to result in notable weight gain or in weight maintenance in patients with advanced cancer. Interventions other than PARP inhibitors should be considered for the palliation/treatment of cancer-associated weight loss.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Doles</LastName>\n                    <ForeName>Jason D</ForeName>\n                    <Initials>JD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hogan</LastName>\n                    <ForeName>Kelly A</ForeName>\n                    <Initials>KA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>O\'Connor</LastName>\n                    <ForeName>Jennifer</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>2 Department of Oncology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wahner Hendrickson</LastName>\n                    <ForeName>Andrea E</ForeName>\n                    <Initials>AE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>2 Department of Oncology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Huston</LastName>\n                    <ForeName>Olivia</ForeName>\n                    <Initials>O</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>2 Department of Oncology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jatoi</LastName>\n                    <ForeName>Aminah</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>2 Department of Oncology, Mayo Clinic , Rochester, Minnesota.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>R01 CA195473</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>24</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Palliat Med</MedlineTA>\n            <NlmUniqueID>9808462</NlmUniqueID>\n            <ISSNLinking>1557-7740</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001562">Benzimidazoles</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000067856">Poly(ADP-ribose) Polymerase Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D059003">Topoisomerase Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>01O4K0631N</RegistryNumber>\n                <NameOfSubstance UI="C521013">veliparib</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>7M7YKX2N15</RegistryNumber>\n                <NameOfSubstance UI="D019772">Topotecan</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001562" MajorTopicYN="N">Benzimidazoles</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002100" MajorTopicYN="N">Cachexia</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000067856" MajorTopicYN="N">Poly(ADP-ribose) Polymerase Inhibitors</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D059003" MajorTopicYN="N">Topoisomerase Inhibitors</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019772" MajorTopicYN="N">Topotecan</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">cachexia</Keyword>\n            <Keyword MajorTopicYN="Y">cancer</Keyword>\n            <Keyword MajorTopicYN="Y">veliparib</Keyword>\n            <Keyword MajorTopicYN="Y">weight loss</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29792535</ArticleId>\n            <ArticleId IdType="doi">10.1089/jpm.2018.0023</ArticleId>\n            <ArticleId IdType="pmc">PMC6154444</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Expert Opin Pharmacother. 2003 Jul;4(7):1121-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12831338</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Nucl Med. 2015 May;40(5):437-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25674871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rev. 2012 Jun 12;6(1):e11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25992201</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lipids Health Dis. 2011 Dec 20;10:238</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22182284</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Cell Cardiol. 2006 Jul;41(1):149-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16716347</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Scand J Gastroenterol. 2016 Jul;51(7):842-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27001198</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):785-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16596378</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2004 Jun 15;22(12):2469-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15197210</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Transplantation. 1968 May;6(3):351-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">5654092</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2013 Apr 20;31(12):1539-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23530101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 2009 Mar;37(4):e26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19151088</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Aug 10;8(45):79884-79896</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29108370</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Cancer. 2016 Sep;2(9):461-463</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28459108</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Aging (Albany NY). 2014 Oct;6(10):820-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25361036</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2018 Feb 15;24(4):744-752</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29138343</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Surg. 2005 Apr;140(4):344-51; discussion 351-2</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15837884</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Radiology. 2012 Jun;263(3):836-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22623697</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Pharmacol. 2001 Jan 1;61(1):119-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11137716</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Clin Oncol. 2013 Feb;10(2):90-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23207794</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Rev Oncol Hematol. 2017 Sep;117:30-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28807233</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Jul 28;10(7):e0134227</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26218895</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Surg Res. 2006 Oct;135(2):233-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16872633</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epigenomics. 2017 Sep 25;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28942676</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Metab. 2011 Apr 6;13(4):461-468</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21459330</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 2013 Jan;182(1):71-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23260200</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2016 Apr;17(4):519-531</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26906526</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Physiol. 2017 Dec;232(12):3744-3761</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28177129</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2016 Nov 22;115(11):1313-1320</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27824811</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharmacol. 2001 Jun;59(6):1497-505</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11353811</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2014 Oct 30;371(18):1673-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25271389</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Cell Dev Biol. 2016 Jun;54:68-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26529279</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 1986 May 15;37(5):753-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3699934</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2012 Jul 3;104(13):966-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22745470</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2002 Jan 15;20(2):567-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11786587</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Metab. 2014 Jun 3;19(6):1034-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24814482</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Biol. 1999 Jan;19(1):296-306</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9858553</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Biol Med (Maywood). 2017 Mar;242(5):473-481</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27932592</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2001 Apr 20;84(8):1135-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11308266</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Appl Physiol Nutr Metab. 2014 Jun;39(6):693-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24869973</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2006 Feb 17;532(1-2):38-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16448648</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Metab. 2014 Sep 2;20(3):433-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25043816</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Surg. 2013 Dec;258(6):1087-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23549425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'